Immutep LimitedIMMPNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank75
3Y CAGR-0.8%
5Y CAGR-58.2%
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

3Y CAGR
-0.8%/yr
vs +65.5%/yr prior
5Y CAGR
-58.2%/yr
Recent acceleration
Acceleration
-66.3pp
Decelerating
Percentile
P75
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q4 202523.10%
Q2 20254.19%
Q4 20244.52%
Q2 2024-15.65%
Q4 2023-77.03%
Q2 2023-5.71%
Q4 202219.79%
Q2 20222.95%
Q4 202181.70%
Q2 2021-14.36%
Q4 2020-1.62%
Q2 2020-21.64%
Q4 201923.65%
Q2 2019272.44%
Q4 20180.25%
Q2 2018-18.76%
Q4 2017314.19%
Q2 2017-54.42%
Q4 201616.68%
Q2 2016-96.49%
Q4 20151816.41%
Q2 2015-11.00%
Q4 201460.87%
Q2 2014-14.85%
Q4 2013-10.88%
Q2 20134.60%
Q4 20120.00%
Q2 20120.00%
Q4 201138.84%
Q2 20110.00%
Q4 201077.91%
Q2 20100.00%
Q4 200983.62%
Q2 20090.00%
Q4 200810.53%
Q2 20080.00%
Q4 20070.00%